Sign in to follow
Search Results

0 results for 'Eli Lilly'

You can use to get even better search results
December 07, 2006 |

Fake Drugs Create a Bitter Pill for Patients Overseas

In the United States, the most commonly counterfeited drugs are "lifestyle" medicines like Viagra, but in poor countries, it's the life-saving drugs that are fakes. Almost half of medicines in developing countries are counterfeit, according to the World Health Organization. Big Pharma doesn't like to talk about the issue, and authorities in poor countries don't have the resources to fight it. Even when they do, counterfeiters can always find a cheaper, less regulated place to go. Is a solution possible?
11 minute read
Federal Circuit Overturns Record-Setting $1.67 Billion Jury Verdict Against Abbott, Rules Centocor Arthritis Drug Patent Is Invalid Under Written Description Requirement
Publication Date: 2011-02-23
Practice Area:
Industry:
Court:
Judge:
Attorneys:
For plaintiff:
For defendant:
Case number:

After he lost the 2009 trial in Marshall, Tx., Bill Lee of Wilmer told us he was sure Abbott would be vindicated on appeal. He was right.

October 01, 2003 |

Let 100 Capitalists Bloom

Hen Honda Motor Co., Ltd., announced in January that it would build a new factory in the southern Chinese province of Guangzhou, the Japanese carmaker's international rivals scoffed at the news. Despite China's cheap labor, building cars there remains expensive compared with Japan, Europe, and the United States; the cost of importing sophisticated car parts far outweighs savings from wages.
10 minute read
March 18, 2004 |

As Other IP Boutiques Falter, Finnegan Moves Forward

Finnegan, Henderson, Farabow, Garrett & Dunner stands as perhaps the healthiest IP boutique in the country -- at a time when other IP specialists have collapsed because of competitive pressure from general service firms, management woes and a turbulent economy. Finnegan's recipe for success includes high-end litigation, a deep bench of institutional clients, a clear succession plan and IP stars like partner Donald Dunner.
11 minute read
Supreme Court Denies Cert in $100 Million Novartis Pharma Sales Rep Overtime Class Action
Publication Date: 2011-02-28
Practice Area:
Industry:
Court:
Judge:
Attorneys:
For plaintiff:
For defendant:
Case number:

Despite an apparent split between the Second and Ninth Circuits on the question of whether drug company sales reps are entitled to overtime, the Supreme Court decided to let stand an appellate ruling permitting a 2,700-plaintiff class action against Novartis to proceed to damages.

Merck Agrees Settle DOJ Claims over Vioxx Marketing for $950 Million
Publication Date: 2011-11-22
Practice Area:
Industry:
Court:
Judge:
Attorneys:
For plaintiff:
For defendant:
Case number:

Merck became just the latest healthcare company to strike a major settlement with the Justice Department on Tuesday, agreeing to a $321.6 million criminal fine and a $628.3 million civil settlement to resolve claims over its marketing of the painkiller Vioxx.

September 26, 2005 |

2005 Revoked List

Notice to the bar.
317 minute read
Congress on Verge of Giving False Claims Act Suits a Boost, Just When They Don't Need One
Publication Date: 2009-05-01
Practice Area:
Industry:
Court:
Judge:
Attorneys:
For plaintiff:
For defendant:
Case number:

When the Supreme Court restricted FCA cases against subcontractors in its Allison Engine ruling, whistle-blower lawyers said the court misunderstood congressional intent. The Senate last week passed fast-track legislation to reverse the effects of the high court's ruling--but in the meantime, the Justice Department is settling FCA suits like nobody's business.

Facing Customer Indemnification Demands, Microsoft Calls Another Infringement Filer's Patents Invalid
Publication Date: 2011-04-12
Practice Area:
Industry:
Court:
Judge:
Attorneys:
For plaintiff:
For defendant:
Case number:

Microsoft is apparently fed up with patent holding companies allegedly shaking down its customers in East Texas patent suits. The target this time: DataTern, which has sued at least 122 companies since 2008 for allegedly infringing its database software patents.

December 08, 2004 |

Merck Looks to Big-Time Firms for Vioxx Cases

With the initial glare of public scrutiny and market recoil over Vioxx behind it, Merck & Co. now is arming for another battle that will be key in determining the company's survival.
9 minute read

TRENDING STORIES

    More from ALM

    More from ALM

    Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

    Resources